Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial
- PMID: 20308618
- DOI: 10.1161/CIRCULATIONAHA.109.873224
Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial
Abstract
Background: The Danish Acute Myocardial Infarction 2 (DANAMI-2) study found that primary angioplasty (primary percutaneous coronary intervention [pPCI]) compared with fibrinolysis reduced 30-day adverse events in patients with ST-segment elevation myocardial infarction. The present study investigated whether the benefit of pPCI was maintained at a long-term follow-up.
Methods and results: We randomly assigned 1572 patients with ST-segment elevation myocardial infarction-1129 patients at referral hospitals and 443 patients at invasive hospitals-to pPCI or fibrinolysis. Median time from randomization to arrival in the catheterization laboratory for patients admitted to referral hospitals was 67 minutes, with 96% of patients arriving in the catheterization laboratory within 120 minutes. The primary study end point was a composite of death or reinfarction. Median follow-up time was 7.8 years. For the primary end point, 8-year cumulative incidence (1-Kaplan-Meier) was 34.8% in the pPCI group and 41.3% in the fibrinolysis group (hazard ratio, 0.78; 95% confidence interval, 0.66 to 0.92). Reinfarction rates were reduced in the pPCI group (11.7% versus 18.5%; hazard ratio, 0.60; 95% confidence interval, 0.46 to 0.77). Among patients randomized at referral hospitals, pPCI reduced reinfarction (13% versus 18.5%; hazard ratio, 0.66; 95% confidence interval, 0.49 to 0.89) and mortality (26.7% versus 33.3%; hazard ratio, 0.78; 95% confidence interval, 0.63 to 0.97).
Conclusions: The benefit of pPCI over fibrinolysis was maintained at a long-term follow-up. pPCI reduced the risk of reinfarction in the overall cohort and reduced reinfarction and mortality among patients randomized at referral hospitals. This result reinforces that pPCI should be offered to ST-segment elevation myocardial infarction patients when interhospital transport to an invasive hospital can be completed within 120 minutes.
Comment in
-
Primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is more effective than fibrinolysis at reducing the composite outcome of death or reinfarction after 8 years.Evid Based Med. 2010 Oct;15(5):145-6. doi: 10.1136/ebm1108. Epub 2010 Aug 5. Evid Based Med. 2010. PMID: 20688845 No abstract available.
-
Letter by Fresco regarding article "Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish Acute Myocardial Infarction 2 trial".Circulation. 2010 Dec 21;122(25):e640; author reply e641. doi: 10.1161/CIRCULATIONAHA.110.958132. Circulation. 2010. PMID: 21173360 No abstract available.
Similar articles
-
Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).J Am Coll Cardiol. 2009 Nov 3;54(19):1763-9. doi: 10.1016/j.jacc.2009.03.084. J Am Coll Cardiol. 2009. PMID: 19874989 Clinical Trial.
-
Letter by Fresco regarding article "Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish Acute Myocardial Infarction 2 trial".Circulation. 2010 Dec 21;122(25):e640; author reply e641. doi: 10.1161/CIRCULATIONAHA.110.958132. Circulation. 2010. PMID: 21173360 No abstract available.
-
Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).Am J Cardiol. 2005 Dec 1;96(11):1469-75. doi: 10.1016/j.amjcard.2005.07.053. Epub 2005 Oct 11. Am J Cardiol. 2005. PMID: 16310424 Clinical Trial.
-
Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction.Am J Cardiol. 2011 Apr 1;107(7):1001-9. doi: 10.1016/j.amjcard.2010.11.024. Epub 2011 Jan 20. Am J Cardiol. 2011. PMID: 21256466 Review.
-
The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI).J Emerg Med. 2008 May;34(4):405-16. doi: 10.1016/j.jemermed.2007.02.068. Epub 2007 Dec 27. J Emerg Med. 2008. PMID: 18164167 Review.
Cited by
-
STEMI time delays: a clinical perspective : Editorial comment on the article by Verweij et al.Neth Heart J. 2015 Aug;23(9):415-9. doi: 10.1007/s12471-015-0728-z. Neth Heart J. 2015. PMID: 26187608 Free PMC article.
-
One-year mortality in patients with acute ST-elevation myocardial infarction in the Vienna STEMI registry.Wien Klin Wochenschr. 2015 Jul;127(13-14):535-42. doi: 10.1007/s00508-015-0827-2. Epub 2015 Jul 11. Wien Klin Wochenschr. 2015. PMID: 26162464
-
Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction.Clin Res Cardiol. 2021 May;110(5):711-724. doi: 10.1007/s00392-020-01685-y. Epub 2020 Jun 8. Clin Res Cardiol. 2021. PMID: 32514602
-
Cardiac monocytes and macrophages after myocardial infarction.Cardiovasc Res. 2020 May 1;116(6):1101-1112. doi: 10.1093/cvr/cvz336. Cardiovasc Res. 2020. PMID: 31841135 Free PMC article. Review.
-
Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.PLoS One. 2012;7(7):e42038. doi: 10.1371/journal.pone.0042038. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22860052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical